Valhi (VHI) Q3 2026 earnings summary

Executive summary

• Q3 2026 net income attributable to shareholders was $30.2 million, or $1.06/share, versus a $22.2 million loss, or $0.78/share; 9M income was $54.5 million, or $1.91/share, versus a $4.4 million loss, or $0.15/share.

• Stronger Chemicals results drove the earnings recovery; lower Real Estate operating income partly offset Q3 gains.

Financial highlights

• Q3 revenue and other income rose to $592.3 million from $524.1 million; net sales were $589.0 million versus $503.5 million. 9M revenue and other income reached $1,784.1 million versus $1,635.0 million; net sales were $1,755.2 million versus $1,582.5 million.

• Consolidated operating income was $67.4 million in Q3 versus $8.6 million and $168.0 million for 9M versus $94.2 million; net income was $40.8 million versus a $21.9 million loss in Q3 and $84.1 million versus $8.4 million for 9M.

Segment performance

• Chemicals Q3 sales rose 18% to $541.1 million and operating income was $60.5 million versus a $15.9 million loss; 9M sales rose 12% to $1,609.0 million and operating income reached $115.4 million versus $35.6 million.

• Chemicals benefited from higher volumes and production rates, lower feedstock and production costs, and cost reductions; higher energy and distribution costs and unfavorable FX partly offset gains.

• Component Products Q3 sales were $44.0 million versus $40.0 million and operating income was $6.4 million versus $4.8 million; 9M sales were $128.2 million versus $120.6 million and operating income was $22.4 million versus $17.0 million.

• Real Estate Q3 sales were $3.9 million versus $6.6 million and operating income was $0.5 million versus $19.7 million; 9M sales were $18.0 million versus $20.8 million and operating income was $30.2 million versus $41.6 million.